Akso Health Group Net Margin
The Net Profit Margin of Akso Health Group (AHG) as of Aug 1, 2026 is -134.99 %. In the previous year, Net Profit Margin was -913.38 % — a change of -85.22% (higher).
Get this data via API
Financial Data API
Net Margin
-134.99 %
YoY
-85.22%
Last updated:
Net Profit Margin of Akso Health Group is 2026 -134.99 % . Net Profit Margin of Akso Health Group was 2025 -913.38 % . It decreases by -85.22% higher compared to the previous year.
Akso Health Group's net margin stands at -135.0%, up from -267.0% several years earlier.
Access this data via the Eulerpool API
Akso Health Group Stock analysis
What does Akso Health Group do? Xiaobai Maimai Inc. is a Chinese company headquartered in Beijing. It was founded in 2016 by Xu Xiaoping, a well-known investment fund manager, and other businessmen. The company's name comes from Xu Xiaoping's childhood nickname, which means "little child."
Xiaobai Maimai Inc.'s business model is diverse and includes various sectors such as e-commerce, education, culture, health, and social services. The company's main activities focus on providing online platforms and software applications for various purposes.
The company offers a variety of products and services, including online marketplaces like Xiaobai Maimai Marketplace where consumers can purchase products and services from merchants. Xiaobai Maimai also operates Xiaobai Maimai University, an online learning platform where users can take courses on various topics taught by industry experts.
Additionally, the company operates Xiaobai Health, an online platform for healthcare services where users can find information and advice on various health topics. This includes the sale of pharmacy products through an online store.
The company is also involved in the cultural industry and operates an online platform for artistic services. Through the platform, businesses and individual customers can book artists and other entertainment services for their events.
The story of Xiaobai Maimai Inc. began when Xu Xiaoping and his partners recognized the great need for online platforms in various industries in China. Due to the rapid growth of the Chinese economy in recent years, the demand for such platforms has been increasing. The company started with Xiaobai Maimai Marketplace and quickly expanded its activities to other areas.
Since its inception, Xiaobai Maimai Inc. has received several investments, including a 150 million RMB investment from the Chinese government's fund for innovation and enterprise development. The company has also partnered with the Beijing Science and Technology Commission to promote innovation in the city.
Overall, Xiaobai Maimai Inc. has had a significant impact on the Chinese economy and society in a short period. The company has helped meet the need for online platforms in various industries and has made a significant contribution to the digital transformation of the Chinese economy. Akso Health Group is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Akso Health Group stock
Net Profit Margin of Akso Health Group is -134.99 % in 2026.
Access this data via the Eulerpool API
Margins — Akso Health Group
All Key Metrics — Akso Health Group
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth